High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19.
Saved in:
| Title: | High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19. |
|---|---|
| Authors: | Haynes WA; Serimmune, Inc., Goleta, CA, USA., Kamath K; Serimmune, Inc., Goleta, CA, USA., Bozekowski J; Serimmune, Inc., Goleta, CA, USA., Baum-Jones E; Serimmune, Inc., Goleta, CA, USA., Campbell M; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Casanovas-Massana A; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Daugherty PS; Serimmune, Inc., Goleta, CA, USA., Dela Cruz CS; Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT, USA., Dhal A; Serimmune, Inc., Goleta, CA, USA., Farhadian SF; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA., Fitzgibbons L; Santa Barbara Cottage Hospital, Santa Barbara, CA, USA., Fournier J; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Jhatro M; Serimmune, Inc., Goleta, CA, USA., Jordan G; Serimmune, Inc., Goleta, CA, USA., Klein J; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Lucas C; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Kessler D; New York Blood Center, New York, NY, USA., Luchsinger LL; New York Blood Center, New York, NY, USA., Martinez B; Serimmune, Inc., Goleta, CA, USA., Catherine Muenker M; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Pischel L; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA., Reifert J; Serimmune, Inc., Goleta, CA, USA., Sawyer JR; Serimmune, Inc., Goleta, CA, USA., Waitz R; Serimmune, Inc., Goleta, CA, USA., Wunder EA Jr; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Zhang M; Serimmune, Inc., Goleta, CA, USA., Iwasaki A; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Ko A; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Shon JC; Serimmune, Inc., Goleta, CA, USA. john.shon@serimmune.com. |
| Corporate Authors: | Yale IMPACT Team |
| Source: | Communications biology [Commun Biol] 2021 Nov 22; Vol. 4 (1), pp. 1317. Date of Electronic Publication: 2021 Nov 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2399-3642 |
|---|---|
| DOI: | 10.1038/s42003-021-02835-2 |
